RxDoctor Payments Data

Efrem Cox, MD

Neurological Surgery · Las Vegas, NVNPI 1841581527

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Stryker at 56.2% of the total. Reporting peaked in 2022 at $17,957 and has fallen 86.8% since, to $2,376 in 2025.

$44,702in general payments, 2019–2025

Across 433 payments — averaging $103.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$25K
  • Johnson & Johnson$6K
  • Globus Medical$4K
  • Providence Medical Technology, Inc.$3K
  • Medical Device Business Services, Inc.$2K
  • Spineology Inc.$629
  • plus $4K from 19 others

What the payments were for

  • Consulting fees$23,30052%
  • Speaking & faculty fees$2321%
  • Travel & lodging$4,53210%
  • Food & beverage$16,63837%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,702 in reported general payments places this provider in the 75th percentile of 45 neurological surgery providers in Nevada.

See all neurological surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$79,725
Medicare patients
226
Services billed
351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin140$1,220
Methocarbamol124$1,200
Meloxicam268$584
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$152
Pregabalin13$125
Cyclobenzaprine Hcl11$90
Tizanidine Hcl11$47

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →